Phase II Data May Be Good Sign For 8mg Aflibercept, But Will Payers Bite?

Female eye with long eyelashes close up. Closeup shot of female gray - blue colour eye with day makeup. Beauty female eye with curl long eyelashes
Regeneron announced Phase II data for aflibercept 8mg in wet AMD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Sensory

More from Therapy Areas